Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia
Clinical trial NCT01543477 · COMPLETED
Trial details
- NCT number
- NCT01543477
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-07-07
- Primary completion
- 2020-04-29
- Enrollment
- 4501
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.